Ionotropic glutamate receptors

Current Opinion in Chemical Biology

Volumn 3, Issue 4, 1999, Pages 441-447

  Bigge, Christopher F ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; IONOTROPIC RECEPTOR; KAINIC ACID RECEPTOR; RECEPTOR SUBUNIT;

CONFORMATIONAL TRANSITION; HUMAN; ION TRANSPORT; MACROMOLECULE; NONHUMAN; PHARMACOLOGY; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; REVIEW; SYNAPSE;

EID: 0033178688     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(99)80065-9     Document Type: Article

References (50)

1. Dingledine R, Borges K, Bowie D, Traynelis SF: The glutamate receptor ion channels. Pharmacol Rev 1999, 51 :7-61. This is an outstanding, comprehensive review of all aspects of iGluRs. The authors provide insight and interpretation into a vastly complex topic. It is a must read.
2. Michaelis EK: Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol 1998, 54:369-415.
3. Bleakman D, Lodge D: Neuropharmacology of AMPA and kainate receptors. Neuropharmacol 1998, 37:1187-1204.
4. Seeburg PH, Higuchi M, Sprengel R: RNA editing of brain glutamate receptor channels: Mechanism and physiology. Brain Res Rev 1998, 26:217-229.
5. .]
6. Rosenmund C, Stern-Bach Y, Stephens CF: The tetrameric structure of the glutamate receptor channel. Science 1998, 280:1596-1599. These two references provide experimental evidence that iGluR receptors exist as tetrameric complexes rather than pentameric subunit complexes, as was previously supposed. The findings of these papers are not final proof, and further physical evidence is required to clarify the issue.
7. Armstrong N, Sun Y, Chen G-Q, Gouaux E: Structure of a glutamate-receptor ligand-binding core in complex with kainate. Nature 1998, 395:913-917. The authors describe a crystal structure of the iGluR-binding region in a complex with the neurotoxin kainic acid. This is a seminal paper and confirms much of which was modelled previously using E. coli glutamine-binding protein. The report identifies determinants of receptor-agonist interactions and describes how ligand specificity and affinity can be affected by remote amino acid residues. Understanding the recognition site at this level is critical for drug discovery efforts.
8. Paas Y: The macro- and microarchitectures of the ligand-binding domain of glutamate receptors. Trends Neurosci 1998, 21:117-125.
9. Standley S, Tocco G, Wagle N, Baudry M: High- and low-affinity AMPA binding sites represent immature and mature forms of AMPA receptors and are composed of differentially glycosylated subunits. J Neurochem 1998, 70:2434-2445.
10. Keinanen K, Jouppila A, Kuusinen A: Characterization of the kainate-binding domain of the glutamate receptor GluR6 subunit. Biochem J 1998, 330:1461-1467.
11. Swanson GT, Green T, Heinemann SF: Kainate receptors exhibit differential sensitivities to (S)-5-iodowillardine. Mol Pharmacol 1998, 53:942-949.
12. Anson LC, Chen PE, Wyllie DJA, Colquhoun D, Schoepfer R: Identification of amino acid residues of the NR2A subunit that control glutamate potency in recombinant NR1/NR2A NMDA receptors. J Neurosci 1998, 18:581-589.
13. Ivanovic A, Reilander H, Laube B, Kuhse J: Expression and initial characterization of a soluble glycine binding domain of the N-methyl-D-aspartate receptor NR1 subunit J Biol Chem 1998, 273:19933-19937.
14. Brusa R, Zimmermann F, Koh D-S, Feldmeyer D, Gass P, Seeburg PH, Sprengel R: Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 1995, 270:1677-1680.
15. Gerlai R, Henderson JT, Roder JC, Jia Z: Multiple behavioral anomalies in GluR2 mutant mice exhibiting enhanced LTP. Behav Brain Res 1998, 95:37-45.
16. Friedman LK, Veliskova J: GluR2 hippocampal knockdown reveals developmental regulation of epileptogenicity and neurodegeneration. Mol Brain Res 1998, 61:224-231.
17. Krupp JJ, Vissel B, Heinemann SF, Westbrook GL: N-terminal domains in the NR2 subunit control desensitization of NMDA receptors. Neuron 1998, 20:317-327.
18. Sekiguchi M, Fleck MW, Mayer ML, Takeo J, Chiba Y, Yamashita S, Wada K: A novel allosteric potentiator of AMPA receptors: 4-2[(phenylsulfonyl-amino)ethylthio]-2,6-difluoro-phenoxyacetamide. J Neurosci 1997, 17:5760-5771.
19. Sekiguchi M, Takeo J, Harada T, Morimoto T, Kudo Y, Yamashita S, Kohsaka S, Wada K: Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures. Br J Pharmacol 1998, 123:1294-1303. The discovery of phenylsulfonyl-aminoethylthio-2,6-difluoro-phenotyncetamide (PEPA) as an allosteric potentiator of AMPA receptors with the flop splice variant is useful to dissect receptor heterogeneity. PEPA is complementary to the action of cyclothiazide that prefers flip splice variants, and is potentially useful for investigating new therapeutic agents as AMPA receptors with the flop variant are found more frequently in mature receptor populations.
20. Krupp JJ, Vissel B, Heinemann SF, Westbrook GL: N-terminal domains in the NR2 subunit control desensitization of NMDA receptors. Neuron 1998, 20:317-327. Little has been know about glycine-independent desensitization of N-methyl-D-aspartic acid (NMDA) receptors. This paper provides structural information relating to three critical domains on the NR2 subunit, and identifies their potential roles in desensitization. The authors propose a model that describes the mechanical events that may occur to initiate this process.
21. Ehlers MD, Fung ET, O'Brien RJ, Huganir RL: Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments. J Neurosci 1998, 18:720-730.
22. 2+-dependent inactivation of NMDA receptors. J Neurosci 1999, 19:1165-1178.
23. Zhang S, Ehlers MD, Bernhardt JP, Su CT, Huganir RL: Calmodulin mediates calcium-dependent inactivation of N-methyl-D-aspartate receptors. Neuron 1998, 21:443-453.
24. Allsion DW, Gelfand VI, Spector I, Craig AM: Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons: Differential attachment of NMDA versus AMPA receptors. J Neurosci 1998, 18:2423-2436.
25. FieldS S, Song O: A novel genetic system to detect protein-protein interactions. Nature 1989, 340:245-246.
26. O'Brien RJ, Lau L-F, Huganir RL: Molecular mechanisms of glutamate receptor clustering at excitatory synapses. Curr Opin Neurobiol 1998, 8:364-369. A brief review that provides entry into the literature of synaptic superstructure and possible mechanisms of receptor clustering.
27. Kornau HC, Seeburg PH, Kennedy MB: Interaction of ion channels and receptors with PDZ domain proteins. Curr Opin Neurobiol 1997, 7:368-373.
28. Dong H, O'Brien RJ, Fung ET, Lanahan AA, Worley PF, Huganir RL: A synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature 1997, 386:279-284.
29. Lin JW, Sheng M: NSF and AMPA receptors get physical. Neuron 1998, 21:267-270.
30. Nishimune A, Isaac JTR, Molnar E, Noel J, Nash SR, Tagaya M, Collingridge GL, Nakanishi S, Henley JM: NSF binding to GluR2 regulates synaptic transmission. Neuron 1998, 21:87-97.
31. Osten P, Srivastava S, Inman GJ, Vilim FS, Khatri L, Lee LM, States BA, Einheber S, Milner TA, Hanson PI, Ziff EB: The AMPA receptor GluR2 C terminus can mediate a reversible ATP-dependent interaction with nsf and α- and β-SNAPS. Neuron 1998, 21:99-110.
32. Song I, Kamboj S, Xia J, Dong H, Liao D, Huganir RL: Interaction of the N-ethylmaleimide-sensitive factor with AMPA receptors. Neuron 1998, 21:393-400.
33. Wyszynski M, Lin J, Rao A, Nigh E, Beggs AH, Craig AM, Sheng M: Competitive binding of α-actinin and calmodulin to the NMDA receptor. Nature 1997, 385:439-442.
34. Rao A, Kim E, Sheng M, Craig AM: Heterogeneity in the molecular composition of excitatory postsynaptic sites during development of hippocampal neurons in culture. J Neurosci 1998, 18:1217-1229. The authors investigated the distribution of proteins interacting with N-methyl-D-aspartic (NMDA) acid receptors and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. Synapse development proceeds by formation of a postsynaptic scaffold containing PSD-95 and guanylate kinase domain-associated protein in concert with pre-synaptic vesicle clustering, and subsequent regulated attachment of glutamate receptor subtypes to the scaffold.
35. Irie M, Hata Y, Takeuchi M, Ichtchenko K, Toyoda A, Hirao K, Takai Y, Rosahl TW, Sudhof TC: Binding of neuroligins to PSD-95. Science 1997, 277:1511-1515.
36. Shen K, Meyer T: Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation. Science 1999, 284:162-166.
37. Snyder GL, Fienberg AA, Huganir RL, Greengard P: A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 Kda)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. J Neurosci 1998, 18:10297-10303.
38. Chabot C, Gagne J, Giguere C, Bernard J, Baudry M, Massicotte G: Bidirectional modulation of AMPA receptor properties by exogenous phospholipase A2 in the hippocampus. Hippocampus 1998, 8:299-309.
39. Clarke VR, Ballyk BA, Hoo KH, Mandelzys A, Pellizzari A, Bath CP, Thomas J, Sharpe EF, Davies CH, Ornstein PL et al.: A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature 1997, 389:599-603.
40. Swanson GT, Heinemann SF: Heterogeneity of homomeric GluR5 kainate receptor desensitization expressed in HEK293 cells. J Physiol 1998, 513:639-646.
41. Procter MJ, Houghton AK, Faber ESL, Chizh BA, Ornstein PL, Lodge D, Headley PM: Actions of kainate and AMPA selective glutamate receptor ligands on nociceptive processing in the spinal cord. Neuropharmacol 1998, 37:1287-1297.
42. Simmons RMA, Li DL, Hoo KH, Deverill M, Ornstein PL, Lyengar S: Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat Neuropharmacol 1998, 37:25-36.
43. Cossart R, Esclapez M, Hirsch JC, Bernard C, Ben-Ari Y: GluR5 kainate receptor activation in interneurons increases tonic inhibition of pyramidal cells. Nature Neurosci 1998, 1:470-478.
44. Castillo PE, Malenka RC, Nicoll RA: Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature 1997, 388:182-186.
45. Malva JO, Carvalho AP, Carvalho CM: Kainate receptors in hippocampal CA3 subregion: Evidence for a role in regulating neurotransmitter release. Neurochem Int 1998, 32:1-6.
46. Mulle C, Sailer A, Perez-Otano I, Dickinson-Anson H, Castillo PE, Bureau I, Maron C, Gage FH, Mann JR, Bettler B, Heinemann SF: Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature 1998, 392:601-605.
47. Bureau I, Bischoff S, Heinemann SF, Mulle C: Kainate receptor mediated responses in the CA1 field of wild-type and GluR6-deficient mice. J Neurosci 1999, 19:653-663. This Paper Dissects The Role of Kainate Receptor Subunits at Hippocampal Synapses. Kainate Receptor Activation Increases The Frequency of Inhibitory Postsynaptic Currents in CA1 Pyramidal Cells and Increases Activity of Gabaergic Interneurons in the CA1 Field. The Results Help Define PhysiologIcal Actions of Subtypes of Kainate Receptors.
48. Kew JNC, Richards JG, Mutel V, Kemp JA: Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons. J Neurosci 1998, 18:1935-1943.
49. Kew JNC, Trube G, Kemp JA: State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist, Br J Pharmacol 1998, 123:463-472.
50. Dunah AW, Luo J, Wang Y-H, Yasuda RP, Wolfe BB: Subunit omposition of NMDA receptors in the rat central nervous system that contain the NR2D subunit. Mol Pharmacol 1998, 53:429-437.